certify
HomeThorne HealthTech Collaborates With Legacy Community Health Services

Thorne HealthTech Collaborates With Legacy Community Health Services

Thorne HealthTech’s health intelligence unit, Onegevity, has entered into a collaboration with Legacy Community Health Services, Inc., the largest Federally Qualified Health Center in Texas, and its advisor and venture studio Design Run Group.

As part of the collaboration, Thorne HealthTech will launch a Thorne Lab, previously known as Lab100, as part of Legacy’s Senior Care Program. The first Thorne Lab will be constructed in Missouri City, Texas, and is expected to open in the spring of 2022. 

Onegevity, Thorne HealthTech’s AI and health intelligence engine – combining a proprietary, multi-omic platform with AI to provide actionable insights to customers with enhanced information and effective products to improve their health – will provide software to power multi-faceted assessments – from 3D body shape measurements, cognition testing, strength and balance and more – within the Senior Care Clinic as well as data analysis and insight generation using its AI and machine learning algorithms, a prepared statement said. 

Use of AI

The Thorne Lab will support Legacy’s commitment to helping patients focus on preventive care and wellness and will bring actionable programs for customers to follow. The ability to implement data-driven insights to improve care for communities that lack such access and connect it to Legacy’s primary care setting is a first of its kind implementation.

“Onegevity’s software, AI and data analysis capabilities are uniquely positioned to help Legacy pioneer a new, customer-centric approach to health and wellness. We are excited to support Legacy’s commitment to serving its communities and promoting better health,” said Thorne HealthTech’s Chief Executive Officer, Paul Jacobson.

READ
Will Novoheart Make Animal Testing Obsolete?

Robert Hilliard, Legacy’s Chief Executive Officer, said the new initiative will serve as an innovative model in improving patient’s overall health and wellness in “a more holistic, efficient and provocative way.”

Legacy’s innovation and design advisor, the Design Run Group, will bring an entrepreneurial and human-centered design approach, integrating with Onegevity’s robust health diagnostic portfolio to facilitate an insight-driven primary care journey for aging adults. If successful, Legacy plans to expand Thorne Labs to additional locations in the future.

Thorne leverages on data and technology, to upgrade the routine physical by offering a wellness-focused doctor’s visit, including vital signs, blood work, and a 3D body scan; cognitive, strength, dexterity, and balance tests; optional gut microbiome analysis and DNA sequencing.

More collaborations

In April, Onegevity began a collaboration with EmbodyBio, a startup company at the forefront of “digital twin” technology, aimed at creating next-generation capabilities to advance brain health.

The collaboration utilizes a new computational systems physiology model of brain health that incorporates data from hundreds of scientific publications and combines them to simulate disease processes across the adult lifespan. It will also generate proprietary modeling solutions by Onegevity, starting in Alzheimer’s disease and expanding to other neurodegenerative diseases, which may be applied in other disease-focused research for pharmaceutical and biotechnology companies. 

READ
Roivant, iNtRON Sign $668 million Licensing Deal For Investigational Drug

Onegevity and EmbodyBio believe this collaboration will fuel deeper personalization in the wellness space for products aimed at brain health, including those manufactured by Thorne, the health technology company under the Thorne HealthTech umbrella that provides supplements and testing solutions to consumers, healthcare professionals, and professional athletes and sports teams.

In early 2021, Thorne merged with Onegevity to form Thorne HealthTech. Thorne HealthTech is a science-driven, vertically integrated wellness platform built to deliver best-in-class, end-to-end nutritional solutions and health intelligence.

“We believe the future of health must be data-driven and wellness-centric, with a guiding focus on preventive medicine in an effort to maintain and extend the healthspan of each individual. The merger of Thorne and Onegevity allows us to deliver on that promise with integrated solutions that are both personalized and deeply rooted in science,” Nathan Price, the Chief Executive Officer of Onegevity, said when the merger was announced in February.

In autumn of 2021, Thorne HealthTech announced its IPO, offering 7,000,000 shares of its common stock at a price of $10 per share. 

READ
Proteus' digital pill system increases medical adherence

Thorne HealthTech’s health intelligence unit, Onegevity, has entered into a collaboration with Legacy Community Health Services, Inc., the largest Federally Qualified Health Center in Texas, and its advisor and venture studio Design Run Group.

As part of the collaboration, Thorne HealthTech will launch a Thorne Lab, previously known as Lab100, as part of Legacy’s Senior Care Program. The first Thorne Lab will be constructed in Missouri City, Texas, and is expected to open in the spring of 2022. 

Onegevity, Thorne HealthTech’s AI and health intelligence engine – combining a proprietary, multi-omic platform with AI to provide actionable insights to customers with enhanced information and effective products to improve their health – will provide software to power multi-faceted assessments – from 3D body shape measurements, cognition testing, strength and balance and more – within the Senior Care Clinic as well as data analysis and insight generation using its AI and machine learning algorithms, a prepared statement said. 

Use of AI

The Thorne Lab will support Legacy’s commitment to helping patients focus on preventive care and wellness and will bring actionable programs for customers to follow. The ability to implement data-driven insights to improve care for communities that lack such access and connect it to Legacy’s primary care setting is a first of its kind implementation.

“Onegevity’s software, AI, and data analysis capabilities are uniquely positioned to help Legacy pioneer a new, customer-centric approach to health and wellness. We are excited to support Legacy’s commitment to serving its communities and promoting better health,” said Thorne HealthTech’s Chief Executive Officer, Paul Jacobson.

READ
Diversity and Inclusion in the Biotech Industry Needs Improving, Report Shows

Robert Hilliard, Legacy’s Chief Executive Officer, said the new initiative will serve as an innovative model in improving patient’s overall health and wellness in “a more holistic, efficient and provocative way.”

Legacy’s innovation and design advisor, the Design Run Group, will bring an entrepreneurial and human-centered design approach, integrating with Onegevity’s robust health diagnostic portfolio to facilitate an insight-driven primary care journey for aging adults. If successful, Legacy plans to expand Thorne Labs to additional locations in the future.

Thorne leverages on data and technology, to upgrade the routine physical by offering a wellness-focused doctor’s visit, including vital signs, blood work, and a 3D body scan; cognitive, strength, dexterity, and balance tests; optional gut microbiome analysis and DNA sequencing.

More collaborations

In April, Onegevity began a collaboration with EmbodyBio, a startup company at the forefront of “digital twin” technology, aimed at creating next-generation capabilities to advance brain health.

The collaboration utilizes a new computational systems physiology model of brain health that incorporates data from hundreds of scientific publications and combines them to simulate disease processes across the adult lifespan. It will also generate proprietary modeling solutions by Onegevity, starting in Alzheimer’s disease and expanding to other neurodegenerative diseases, which may be applied in other disease-focused research for pharmaceutical and biotechnology companies. 

READ
Gates Foundation Funds $100M a year to a Nonprofit biotech startup

Onegevity and EmbodyBio believe this collaboration will fuel deeper personalization in the wellness space for products aimed at brain health, including those manufactured by Thorne, the health technology company under the Thorne HealthTech umbrella that provides supplements and testing solutions to consumers, healthcare professionals, and professional athletes and sports teams.

In early 2021, Thorne merged with Onegevity to form Thorne HealthTech. Thorne HealthTech is a science-driven, vertically integrated wellness platform built to deliver best-in-class, end-to-end nutritional solutions and health intelligence.

“We believe the future of health must be data-driven and wellness-centric, with a guiding focus on preventive medicine in an effort to maintain and extend the healthspan of each individual. The merger of Thorne and Onegevity allows us to deliver on that promise with integrated solutions that are both personalized and deeply rooted in science,” Nathan Price, the Chief Executive Officer of Onegevity, said when the merger was announced in February.

In autumn of 2021, Thorne HealthTech announced its IPO, offering 7,000,000 shares of its common stock at a price of $10 per share. 

banner
Adsense